Abstract
Autoimmune connective tissue diseases are a group of disorders with heterogeneous clinical manifestations; however, they share one common feature, namely, inflammation of connective tissue. In some of these diseases, such as morphea or lichen sclerosus, the disease is limited to the skin, while in others, such as in dermatomyositis, systemic sclerosis, or systemic lupus erythematosus, skin lesions are only one of the possible manifestations of the disease, and the severity of the disease depends on which organs are involved. In this chapter we have focused on the most meaningful skin symptoms, which should help the clinicians and histopathologists making the proper diagnosis; however, we have also included less commonly observed clinical variants to illustrate a wide clinical spectrum of connective tissue diseases.
References
Ackerman AB (1997) Tumid lupus erythematosus. In: Ackerman AB, Congchitnant N, Sanchez J, Guo Y (eds) Histologic diagnosis of inflammatory skin diseases. Williams and Wilkins, Baltimore, p 529
Alarcón GS (2000) Unclassified or undifferentiated connective tissue disease. Baillieres Best Pract Res Clin Rheumatol 14(1):125–137
Allanore Y, Simms R, Distler O, Trojanowska M, Pope J, Denton CP, Varga J (2015) Systemic sclerosis. Nat Rev Dis Primers 1:15002
Alniemi DT, Gutierrez A Jr, Drage LA, Wetter DA (2017) Subacute cutaneous lupus erythematosus: clinical characteristics, disease associations, treatments, and outcomes in a series of 90 patients at mayo clinic, 1996–2011. Mayo Clin Proc 92(3):406–414
Amaral TN, Peres FA, Lapa AT, Marques-Neto JF, Appenzeller S (2013) Neurologic involvement in scleroderma: a systematic review. Semin Arthritis Rheum 43(3):335–347
Andronache IT, Suta C, Ionescu C, Calistrat A, Suta M (2015) Rowell syndrome-a controversial clinical entity. Rom J Rhematol 24(4):230–234
Battagliotti CA (2006) Skin manifestation of antiphospholipid syndrome. In: Khamashta MA (ed) Hughes syndrome. Antiphospholipid syndrome, 2nd edn. Springer, pp 86–98
Bencal-Kusińska M, Mędrek K, Reich A (2015) Lichen sclerosus – hyperkeratotic form. Forum Dermatol 1(1):28–31
Bevans SL, Keeley JM, Sami N (2017) Oral lichen sclerosus – a review of clinical presentation, treatment, and clinical outcomes. Oral Surg Oral Med Oral Pathol Oral Radiol 124(4):e243–e248
Bielsa I, Ariza A (2007) Deep morphea. Semin Cutan Med Surg 26(2):90–95
Bielsa Marsol I (2013) Update on the classification and treatment of localized scleroderma. Actas Dermosifiliogr 104(8):654–666
Bischoff L, Derk CT (2008) Eosinophilic fasciitis: demographics, disease pattern and response to treatment: report of 12 cases and review of the literature. Int J Dermatol 47(1):29–35
Blaya B, Gardeazabal J, de Lagrán ZM, Díaz-Pérez JL (2008) Patient with generalized guttate morphea and lichen sclerosus et atrophicus. Actas Dermosifiliogr 99(10):808–811
Bray VJ (2015) Sjoegren syndrome. In: West SG (ed) Rheumatology secret, 3rd edn. Elsevier Mosby, Philadelphia, pp 171–178
Buyon JP, Clancy RM (2005) Neonatal lupus: basic research and clinical perspectives. Rheum Dis Clin N Am 31(2):299–313
Callen JP (2002) Management of skin disease in patients with lupus erythematosus. Best Pract Res Clin Rheumatol 16(2):245–264
Calonje E, Brenn T, Lazar A, McKee P (2011a) Chondrodermatitis nodularis chronica helicis. In: McKee’s pathology of the skin, 4th edn. Elsevier, Philadelphia, pp 324–325
Calonje E, Brenn T, Lazar A, McKee P (2011b) Polyarteritis nodosa and microscopic polyangiitis. In: McKee’s pathology of the skin, 4th edn. Elsevier, Philadelphia, pp 667–673
Calonje E, Brenn T, Lazar A, McKee P (2011c) Polymyositis/dermatomyositis. In: McKee’s pathology of the skin, 4th edn. Elsevier, Philadelphia, pp 751–756
Calonje E, Brenn T, Lazar A, McKee P (2011d) Rheumatoid nodule. In: McKee’s pathology of the skin, 4th edn. Elsevier, Philadelphia, pp 300–302
Capone C, Buyon JP, Friedman DM, Frishman WH (2012) Cardiac manifestations of neonatal lupus: a review of autoantibody-associated congenital heart block and its impact in an adult population. Cardiol Rev 20(2):72–76
Cardinali C, Caproni M, Bernacchi E, Amato L, Fabbri P (2000) The spectrum of cutaneous manifestations in lupus erythematosus – the Italian experience. Lupus 9(6):417–423
Careta MF, Romiti R (2015) Localized scleroderma: clinical spectrum and therapeutic update. An Bras Dermatol 90(1):62–73
Carlson JA, Lamb P, Malfetano J, Ambros RA, Mihm MC Jr (1998) Clinicopathologic comparison of vulvar and extragenital lichen sclerosus: histologic variants, evolving lesions, and etiology of 141 cases. Mod Pathol 11(9):844–854
Chang AY, Werth VP (2011) Treatment of cutaneous lupus. Curr Rheumatol Rep 13(4):300–307
Chasset F, Bouaziz JD, Costedoat-Chalumeau N, Francès C, Arnaud L (2017) Efficacy and comparison of antimalarials in cutaneous lupus erythematosus subtypes: a systematic review and meta-analysis. Br J Dermatol 177(1):188–196
Cheng W, Gilliam AC, Castrovinci A, Pazirandeh M (2007) Anti-thyroid autoantibody-associated interface dermatitis in individuals with undifferentiated connective tissue disease – an unrecognized subset of autoimmune disease? J Rheumatol 34(1):81–88
Cisneros CG, Romiti R, Santi CG, Aoki V, Valente NY, Nico MM (2010) Toxic epidermal necrolysis-like cutaneous lupus erythematosus: a series of three patients. Acta Derm Venereol 90(2):175–178
Costner MI, Sontheimer RD, Provost TT (2003) Lupus erythematosus. In: Sontheimer RD, Provost TT (eds) Cutaneous manifestations of rheumatic diseases. Williams & Wilkins, Philadelphia, pp 15–64
Crowson AN, Magro C (2001) The cutaneous pathology of lupus erythematosus: a review. J Cutan Pathol 28(1):1–23
Cush JJ, Medsger TA Jr, Christy WC, Herbert DC, Cooperstein LA (1987) Adult-onset Still’s disease. Clinical course and outcome. Arthritis Rheum 30(2):186–194
Daniels TE, Cox D, Shiboski CH, Schiødt M, Wu A, Lanfranchi H, Umehara H, Zhao Y, Challacombe S, Lam MY, De Souza Y, Schiødt J, Holm H, Bisio PA, Gandolfo MS, Sawaki T, Li M, Zhang W, Varghese-Jacob B, Ibsen P, Keszler A, Kurose N, Nojima T, Odell E, Criswell LA, Jordan R, Greenspan JS, Sjögren’s International Collaborative Clinical Alliance Research Groups (2011) Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjögren’s syndrome among 1,726 registry participants. Arthritis Rheum 63(7):2021–2030
David-Bajar KM, Davis BM (1997) Pathology, immunopathology, and immunohistochemistry in cutaneous lupus erythematosus. Lupus 6(2):145–157
De Virgilio A, Greco A, Magliulo G, Gallo A, Ruoppolo G, Conte M, Martellucci S, de Vincentiis M (2016) Polyarteritis nodosa: a contemporary overview. Autoimmun Rev 15(6):564–570
Di Rollo D, Abeni D, Tracanna M, Capo A, Amerio P (2014) Cancer risk in dermatomyositis: a systematic review of the literature. G Ital Dermatol Venereol 149(5):525–537
Duarte AF, Mota A, Pereira M, Baudrier T, Azevedo F (2008) Rowell syndrome – case report and review of the literature. Dermatol Online J 14(3):15
Elhai M, Meune C, Avouac J, Kahan A, Allanore Y (2012) Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies. Rheumatology (Oxford) 51(6):1017–1026
Endo Y, Tamura A, Matsushima Y, Iwasaki T, Hasegawa M, Nagai Y, Ishikawa O (2007) Eosinophilic fasciitis: report of two cases and a systematic review of the literature dealing with clinical variables that predict outcome. Clin Rheumatol 26(9):1445–1451
Fabbri P, Cardinali C, Giomi B, Caproni M (2003) Cutaneous lupus erythematosus: diagnosis and management. Am J Clin Dermatol 4(7):449–465
Fett NM (2012) Morphea: evidence-based recommendations for treatment. Indian J Dermatol Venereol Leprol 78(2):135–141
Fett N, Werth VP (2011) Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis. J Am Acad Dermatol 64(2):217–228
Fisher BA, Brown RM, Bowman SJ, Barone F (2015) A review of salivary gland histopathology in primary Sjögren’s syndrome with a focus on its potential as a clinical trials biomarker. Ann Rheum Dis 74(9):1645–1650
Fistarol SK, Itin PH (2013) Diagnosis and treatment of lichen sclerosus: an update. Am J Clin Dermatol 14(1):27–47
Fleischmajer R, Nedwich A (1972) Generalized morphea. I. Histology of the dermis and subcutaneous tissue. Arch Dermatol 106(4):509–514
Flint SR, Watson R, Provost TT (2004) Mucocutaneous manifestations of Sjoegren syndrome. In: Sontheimer RD, Provost TT (eds) Cutaneous manifestations of rheumatic diseases. Lippincott Williams Wilkins, pp 135–152
Forbess L, Bannykh S (2015) Polyarteritis nodosa. Rheum Dis Clin N Am 41(1):33–46
Garg A, Kumar P (2011) Atrophoderma of pasini and pierini. Indian Dermatol Online J 2(2):126–128
Gilliam JN, Sontheimer RD (1981) Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J Am Acad Dermatol 4(4):471–475
Gopalarathinam R, Orlowsky E, Kesavalu R, Yelaminchili S (2016) Adult onset Still’s disease: a review on diagnostic workup and treatment options. Case Rep Rheumatol 2016:6502373
Grover C, Khurana A, Sharma S, Singal A (2013) Bullous systemic lupus erythematosus. Indian J Dermatol 58(6):492
Hamaguchi Y, Fujimoto M, Matsushita T, Kaji K, Komura K, Hasegawa M, Kodera M, Muroi E, Fujikawa K, Seishima M, Yamada H, Yamada R, Sato S, Takehara K, Kuwana M (2013) Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome. PLoS One 8(4):e60442
Hedrich CM, Fiebig B, Hauck FH, Sallmann S, Hahn G, Pfeiffer C, Heubner G, Lee-Kirsch MA, Gahr M (2008) Chilblain lupus erythematosus – a review of literature. Clin Rheumatol 27(8):949–954
Helm TN, Jones CM (2002) Chilblain lupus erythematosus lesions precipitated by the cold. Cutis 69(3):183–184
Hernández-Rodríguez J, Alba MA, Prieto-González S, Cid MC (2014) Diagnosis and classification of polyarteritis nodosa. J Autoimmun 48–49:84–89
Hetlevik SO, Flatø B, Rygg M, Nordal EB, Brunborg C, Hetland H, Lilleby V (2017) Long-term outcome in juvenile-onset mixed connective tissue disease: a nationwide Norwegian study. Ann Rheum Dis 76(1):159–165
Holl-Ulrich K, Rose C (2016) Non-infectious granulomatous inflammation: focus on the lungs and skin. Pathologe 37(2):172–182
Hon KL, Leung AK (2012) Neonatal lupus erythematosus. Autoimmune Dis 2012:301274
Inzinger M, Salmhofer W, Binder B (2012) Neonatal lupus erythematosus and its clinical variability. J Dtsch Dermatol Ges 10(6):407–411
Jablonska S, Blaszczyk M (1998) Scleromyositis: a scleroderma/polymyositis overlap syndrome. Clin Rheumatol 17(6):465–467
Jablonska S, Blaszyk M (2004) Scleromyositis (scleroderma/polymyositis overlap) is an entity. J Eur Acad Dermatol Venereol 18(3):265–266
Jablonska S, Szczepanski A (1975) Atrophoderma Pasini-Pierini. In: Jablonska S (ed) Scleroderma and pseudoscleroderma. Polish Medical Publishers, pp 521–536
Jacyk WK (2011) Lupus erythematosus profundus (lupus erythematosus panniculitis). Dermatologia Kliniczna 13(4):257–261
Jerdan MS, Hood AF, Moore GW, Callen JP (1990) Histopathologic comparison of the subsets of lupus erythematosus. Arch Dermatol 126(1):52–55
Karri SB, Kannan AM, Rajashekhar L, Uppin MS, Challa S (2015) Clinico-pathological study of adult dermatomyositis: importance of muscle histology in the diagnosis. Ann Indian Acad Neurol 18(2):194–199
Khamashta MA, Bertolaccini ML, Ostensen M (2009) Antiphospholipid syndrome. In: Bijlsma JWJ (ed) Eular compendium on rheumatic diseases, 1st edn. BMJ Publishing Group, London, pp 280–288
Khana W, Alasirib R, Alkhatabib H (2016) Guttate morphea: a case report. Int J Biol Med Res 7(3):5669–5671
Klippel J (2010) The pocket primer on the rheumatic diseases. Springer, London
Knobler R, Moinzadeh P, Hunzelmann N, Kreuter A, Cozzio A, Mouthon L, Cutolo M, Rongioletti F, Denton CP, Rudnicka L, Frasin LA, Smith V, Gabrielli A, Aberer E, Bagot M, Bali G, Bouaziz J, Braae Olesen A, Foeldvari I, Frances C, Jalili A, Just U, Kähäri V, Kárpáti S, Kofoed K, Krasowska D, Olszewska M, Orteu C, Panelius J, Parodi A, Petit A, Quaglino P, Ranki A, Sanchez Schmidt JM, Seneschal J, Skrok A, Sticherling M, Sunderkötter C, Taieb A, Tanew A, Wolf P, Worm M, Wutte NJ, Krieg T (2017) European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin. Part 1: localized scleroderma, systemic sclerosis and overlap syndromes. J Eur Acad Dermatol Venereol 31(9):1401–1424
Kowal-Bielecka O, Fransen J, Avouac J, Becker M, Kulak A, Allanore Y, Distler O, Clements P, Cutolo M, Czirjak L, Damjanov N, Del Galdo F, Denton CP, Distler JHW, Foeldvari I, Figelstone K, Frerix M, Furst DE, Guiducci S, Hunzelmann N, Khanna D, Matucci-Cerinic M, Herrick AL, van den Hoogen F, van Laar JM, Riemekasten G, Silver R, Smith V, Sulli A, Tarner I, Tyndall A, Welling J, Wigley F, Valentini G, Walker UA, Zulian F, Müller-Ladner U, EUSTAR Coauthors (2017) Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis 76(8):1327–1339
Krasowska D, Rudnicka L, Dańczak-Pazdrowska A, Chodorowska G, Woźniacka A, Lis-Święty A, Czuwara J, Maj J, Majewski S, Sysa-Jędrzejowska A, Wojas-Pelc A (2017a) Systemic sclerosis – diagnostic and therapeutic recommendations of the polish dermatological society. Part 1: diagnosis and monitoring. Dermatology Rev 104(5):483–498
Krasowska D, Rudnicka L, Dańczak-Pazdrowska A, Chodorowska G, Woźniacka A, Lis-Święty A, Czuwara J, Maj J, Majewski S, Sysa-Jędrzejowska A, Wojas-Pelc A (2017b) Systemic sclerosis – diagnostic and therapeutic recommendations of the polish dermatological society. Part 2: treatment. Dermatology Rev 104(6):583–596
Kreuter A (2012) Localized scleroderma. Dermatol Ther 25(2):135–147
Kreuter A, Krieg T, Worm M, Wenzel J, Moinzadeh P, Kuhn A, Aberer E, Scharffetter-Kochanek K, Horneff G, Reil E, Weberschock T, Hunzelmann N (2016) German guidelines for the diagnosis and therapy of localized scleroderma. J Dtsch Dermatol Ges 14(2):199–216
Krieg T, Takehara K (2009) Skin disease: a cardinal feature of systemic sclerosis. Rheumatology (Oxford) 48(Suppl 3):iii14–iii18
Kuhn A, Ruzicka T (2004) Classification of cutaneous lupus erythematosus. In: Kuhn A, Lehmann P, Ruzicka T (eds) Cutaneous lupus erythematosus. Springer, Berlin/Heidelberg/New York, pp 53–58
Kuhn A, Richter-Hintz D, Oslislo C, Ruzicka T, Megahed M, Lehmann P (2000) Lupus erythematosus tumidus – a neglected subset of cutaneous lupus erythematosus: report of 40 cases. Arch Dermatol 136(8):1033–1041
Kuhn A, Sonntag M, Richter-Hintz D, Oslislo C, Megahed M, Ruzicka T, Lehmann P (2001) Phototesting in lupus erythematosus tumidus – review of 60 patients. Photochem Photobiol 73(5):532–536
Kuhn A, Sonntag M, Ruzicka T, Lehmann P, Megahed M (2003) Histopathologic findings in lupus erythematosus tumidus: review of 80 patients. J Am Acad Dermatol 48(6):901–908
Kuhn A, Bein D, Bonsmann G (2009) The 100th anniversary of lupus erythematosus tumidus. Autoimmun Rev 8(6):441–448
Lakhanpal S, Ginsburg WW, Michet CJ, Doyle JA, Moore SB (1988) Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases. Semin Arthritis Rheum 17(4):221–231
Larson AR, Laga AC, Granter SR (2015) The spectrum of histopathologic findings in cutaneous lesions in patients with Still disease. Am J Clin Pathol 144(6):945–951
Lebeaux D, Sène D (2012) Eosinophilic fasciitis (Shulman disease). Best Pract Res Clin Rheumatol 26(4):449–458. (we couldn’t find its citation in the context)
Lee JJ, Pope JE (2016) Diagnosis and management of systemic sclerosis: a practical approach. Drugs 76(2):203–213
Lee LA, Werth VP (2012) Lupus erythematosus. In: Bolognia JL (ed) Dermatology, 3rd edn. Elsevier, London, p 601
Lee HY, Tey HL, Pang SM, Thirumoorthy T (2011) Systemic lupus erythematosus presenting as Stevens-Johnson syndrome and toxic epidermal necrolysis: a report of 3 cases. Lupus 20(6):647–652
LeFeber WP, Norris DA, Ryan SR, Huff JC, Lee LA, Kubo M, Boyce ST, Kotzin BL, Weston WLJ (1984) Ultraviolet light induces binding of antibodies to selected nuclear antigens on cultured human keratinocytes. Clin Invest 74(4):1545–1551
Lightfoot RW Jr, Michel BA, Bloch DA, Hunder GG, Zvaifler NJ, McShane DJ, Arend WP, Calabrese LH, Leavitt RY, Lie JT, Masi AF, Mills JA, Stevens MB, Wallace SL (1990) The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 33(5):1088–1093
Magro CM, Crowson AN (2003) The spectrum of cutaneous lesions in rheumatoid arthritis: a clinical and pathological study of 43 patients. J Cutan Pathol 30(1):1–10
Mahler M, Miller FW, Fritzler MJ (2014) Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review. Autoimmun Rev 13(4–5):367–371
Mainetti C, Terziroli Beretta-Piccoli B, Selmi C (2017) Cutaneous manifestations of dermatomyositis: a comprehensive review. Clin Rev Allergy Immunol 53(3):337–356
Mandelcorn R, Shear N (2003) Lupus associated toxic epidermal necrolysis. A novel manifestation of lupus? J Am Acad Dermatol 48(6):525–529
Maragh SH, Davis MD, Bruce AJ, Nelson AM (2005) Disabling pansclerotic morphea: clinical presentation in two adults. J Am Acad Dermatol 53(2 Suppl 1):115–119
Marie I, Gremain V, Nassermadji K, Richard L, Joly P, Menard JF, Levesque H (2017) Nail involvement in systemic sclerosis. J Am Acad Dermatol 76(6):1115–1123
Mariette X, Gottenberg JE, Theander E (2009) Sjoegren’s syndrome and lymphoproliferations in autoimmune diseases. In: Bijlsma JWJ (ed) EULAR compendium on rheumatic diseases, 1st edn. BMJ Publishing Group, London, pp 314–328
Martens PB, Moder KG, Ahmed I (1999) Lupus panniculitis: clinical perspectives from a case series. J Rheumatol 26(1):68–72
Mascaro JM, Herrero C, Hausmann G (1997) Uncommon cutaneous manifestations of lupus erythematosus. Lupus 6(2):122–131
Mazori DR, Femia AN, Vleugels RA (2017) Eosinophilic fasciitis: an updated review on diagnosis and treatment. Curr Rheumatol Rep 19(12):74
Mertens JS, Marsman D, van de Kerkhof PC, Hoppenreijs EP, Knaapen HK, Radstake TR, de Jong EM, Seyger MM (2016) Use of mycophenolate mofetil in patients with severe localized scleroderma resistant or intolerant to methotrexate. Acta Derm Venereol 96(4):510–513
Mertens JS, Seyger MMB, Thurlings RM, Radstake TRDJ, de Jong EMGJ (2017) Morphea and eosinophilic fasciitis: an update. Am J Clin Dermatol 18(4):491–512
Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, DE Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4(2):295–306
Muro Y, Sugiura K, Akiyama M (2016) Cutaneous manifestations in dermatomyositis: key clinical and serological features – a comprehensive review. Clin Rev Allergy Immunol 51(3):293–302
Mutasim DF, Egesi A, Spicknall KE (2016) Wong-type dermatomyositis: a mimic of many dermatoses. J Cutan Pathol 43(9):781–786
Nadaud B, Depaepe L, Zaharia D, Balme B (2014) Chondrodermatitis nodularis helicis. Ann Dermatol Venereol 141(4):306–307
Ng PP, Tan SH, Koh ET, Tan T (2000) Epidemiology of cutaneous lupus erythematosus in a tertiary referral centre in Singapore. Australas J Dermatol 41(4):229–233
Obermoser G, Sontheimer RD, Zelger B (2010) Overview of common, rare and atypical manifestations of cutaneous lupus erythematosus and histopathological correlates. Lupus 19(9):1050–1070
Okon LG, Werth VP (2013) Cutaneous lupus erythematosus: diagnosis and treatment. Best Pract Res Clin Rheumatol 27(3):391–404
Ortega-Hernandez OD, Shoenfeld Y (2012) Mixed connective tissue disease: an overview of clinical manifestations, diagnosis and treatment. Best Pract Res Clin Rheumatol 26(1):61–72
Pagnoux C, Seror R, Henegar C, Mahr A, Cohen P, Le Guern V, Bienvenu B, Mouthon L, Guillevin L, French Vasculitis Study Group (2010) Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database. Arthritis Rheum 62:616–626
Peters MS, Su WPD (1989) Lupus erythematosus panniculitis. Med Clin North Am 73(5):1113–1126
Peterson LS, Nelson AM, Su WP (1995) Classification of morphea (localized scleroderma). Mayo Clin Proc 70(11):1068–1076
Provost TT (2004) Nonspecific cutaneous manifestations of systemic lupus erythematosus. In: Kuhn A, Lehmann P, Ruzicka T (eds) Cutaneous lupus erythematosus. Springer, Berlin/Heidelberg/New York, pp 93–106
Rai R, Handa S, Gupta S, Kumar B (2000) Bilateral en coup de sabre – a rare entity. Pediatr Dermatol 17(3):222–224
Rao TN, Ahmed K, Venkatachalam K (2010) Lupus erythematosus profundus. Indian J Dermatol Venereol Leprol 76(4):448
Rattanakaemakorn P, Jorizzo JL (2017) The efficacy of methotrexate in the treatment of en coup de sabre (linear morphea subtype). J Dermatolog Treat 29(2):197–199
Reich A, Werth VP, Furukawa F, Kuhn A, Szczęch J, Samotij D, Szepietowski JC (2016) Treatment of cutaneous lupus erythematosus: current practice variations. Lupus 25(9):964–972
Reiseter S, Gunnarsson R, Corander J, Haydon J, Lund MB, Aaløkken TM, Taraldsrud E, Hetlevik SO, Molberg Ø (2017) Disease evolution in mixed connective tissue disease: results from a long-term nationwide prospective cohort study. Arthritis Res Ther 19(1):284
Rosenbach M, English JC 3rd (2015) Reactive granulomatous dermatitis: a review of palisaded neutrophilic and granulomatous dermatitis, interstitial granulomatous dermatitis, interstitial granulomatous drug reaction, and a proposed reclassification. Dermatol Clin 33(3):373–387
Rowell NR, Swanson-Beck J, Anderson JR (1963) Lupus erythematosus and erythema multiforme-like lesions. Arch Dermatol 88(2):176–180
Saleh Z, Abbas O, Dahdah MJ, Kibbi AG, Zaynoun S, Ghosn S (2008) Atrophoderma of Pasini and Pierini: a clinical and histopathological study. J Cutan Pathol 35(12):1108–1114
Samotij D, Szczęch J, Reich A (2015) Diagnostic and therapeutic advances in dermatomyositis. Przegl Dermatol 102(3):183–197
Sen S, Sinhamahapatra P, Choudhury S, Gangopadhyay A, Bala S, Sircar G, Chatterjee G, Ghosh A (2014) Cutaneous manifestations of mixed connective tissue disease: study from a tertiary care hospital in eastern India. Indian J Dermatol 59(1):35–40
Seror R, Bowman SJ, Brito-Zeron P, Theander E, Bootsma H, Tzioufas A, Gottenberg JE, Ramos-Casals M, Dörner T, Ravaud P, Vitali C, Mariette X (2015) EULAR Sjoegren’s syndrome disease activity index (ESSDAI): a user guide. RMD Open 1:e000022
Shah S, Fiala KH (2017) Chondrodermatitis nodularis helicis: a review of current therapies. Dermatol Ther 30(1). https://doi.org/10.1111/dth.12434
Simeón-Aznar CP, Fonollosa-Plá V, Tolosa-Vilella C, Espinosa-Garriga G, Campillo-Grau M, Ramos-Casals M, García-Hernández FJ, Castillo-Palma MJ, Sánchez-Román J, Callejas-Rubio JL, Ortego-Centeno N, Egurbide-Arberas MV, Trapiellla-Martínez L, Caminal-Montero L, Sáez-Comet L, Velilla-Marco J, Camps-García MT, de Ramón-Garrido E, Esteban-Marcos EM, Pallarés-Ferreres L, Navarrete-Navarrete N, Vargas-Hitos JA, Gómez de la Torre R, Salvador-Cervello G, Rios-Blanco JJ, Vilardell-Tarrés M, Spanish Scleroderma Study Group (SSSG), Autoimmune Diseases Study Group (GEAS), Spanish Society of Internal Medicine (SEMI) (2015) Registry of the Spanish network for systemic sclerosis: survival, prognostic factors, and causes of death. Medicine (Baltimore) 94(43):e1728
Singh A, Singhal K, Choudhary S, Bisati S, Arora M (2014) Adult-onset unilateral disabling pansclerotic morphea. Indian J Dermatol 59(3):316
Sławińska M, Nowicki RJ, Sobjanek M (2017) Topical nitroglycerin is effective in the treatment of chondrodermatitis nodularis helicis. Forum Dermatol 3(3):79–80
Soma Y, Fujimoto M (1998) Frontoparietal scleroderma (en coup de sabre) following Blaschko’s lines. J Am Acad Dermatol 38(2 Pt 2):366–368
Sommer A, Gambichler T, Bacharach-Buhles M, von Rothenburg T, Altmeyer P, Kreuter A (2006) Clinical and serological characteristics of progressive facial hemiatrophy: a case series of 12 patients. J Am Acad Dermatol 54(2):227–233
Sontheimer RD (1997) The lexicon of cutaneous lupus erythematosus: a review and personal perspective on the nomenclature and classification of the cutaneous manifestations of lupus erythematosus. Lupus 6(2):84–95
Sontheimer RD, Thomas JR, Gilliam J (1979) Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset. Arch Dermatol 115(12):1409–1415
Szczęch J, Rutka M, Samotij D, Zalewska A, Reich A (2016) Clinical characteristics of cutaneous lupus erythematosus. Adv Dermatol Allergol 33(1):13–17
Taniguchi T, Asano Y, Tamaki Z, Akamata K, Aozasa N, Noda S, Takahashi T, Ichimura Y, Toyama T, Sugita M, Sumida H, Kuwano Y, Miyazaki M, Yanaba K, Sato S (2014) Histological features of localized scleroderma ‘en coup de sabre’: a study of 16 cases. J Eur Acad Dermatol Venereol 28:1805–1810
Tilstra JS, Lienesch DW (2015) Rheumatoid nodules. Dermatol Clin 33(3):361–371
Ting W, Stone MS, Racila D, Scofield RH, Sontheimer SD (2004) Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus and the spectrum of the acute syndrome of apoptotic pan-epidermolysis (ASAP): a case report, concept review and proposal for new classification of lupus erythematosus vesiculo-bullous skin lesions. Lupus 13(12):941–950
Tolkachjov SN, Patel NG, Tollefson MM (2015) Progressive hemifacial atrophy: a review. Orphanet J Rare Dis 10:39
Torok KS, Arkachaisri T (2012) Methotrexate and corticosteroids in the treatment of localized scleroderma: a standardized prospective longitudinal single-center study. J Rheumatol 39(2):286–294
Troyanov Y, Targoff IN, Payette MP, Raynauld JP, Chartier S, Goulet JR, Bourré-Tessier J, Rich E, Grodzicky T, Fritzler MJ, Joyal F, Koenig M, Senécal JL (2014) Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features. Medicine (Baltimore) 93(24):318–332
van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE, Riemekasten G, Clements PJ, Denton CP, Distler O, Allanore Y, Furst DE, Gabrielli A, Mayes MD, van Laar JM, Seibold JR, Czirjak L, Steen VD, Inanc M, Kowal-Bielecka O, Müller-Ladner U, Valentini G, Veale DJ, Vonk MC, Walker UA, Chung L, Collier DH, Ellen Csuka M, Fessler BJ, Guiducci S, Herrick A, Hsu VM, Jimenez S, Kahaleh B, Merkel PA, Sierakowski S, Silver RM, Simms RW, Varga J, Pope JE (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum 65(11):2737–2747
Vassileva S (2004) Bullous systemic lupus erythematosus. Clin Dermatol 22(2):129–138
Vieira V, Del Pozo J, Yebra-Pimentel MT, Martínez W, Fonseca E (2006) Lupus erythematosus tumidus: a series of 26 cases. Int J Dermatol 45(5):512–517
Vyas A (2017) Genital lichen sclerosus and its mimics. Obstet Gynecol Clin N Am 44(3):389–406
Walling HW, Sontheimer RD (2009) Cutaneous lupus erythematosus: issues in diagnosis and treatment. Am J Clin Dermatol 10(6):365–381
Watanabe T, Tsuchida T (1996) Lupus erythematosus profundus: a cutaneous marker for a distinct clinical subset? Br J Dermatol 134(1):123–125
Werth VP (2005) Clinical manifestations of cutaneous lupus erythematosus. Autoimmun Rev 4(5):296–302
Werth VP, Vera-Kellet C, Dutz JP (2011) Clinical aspects of disease: skin. In: Lahita RG, Tsokos G, Buyon JP, Koike T (eds) Systemic lupus erythematosus, 5th edn. Academic Press Elsevier, Amsterdam, p 755
West SG, Hansen KE (2015) Antiphospholipid antibody syndrome. In: West SG (ed) Rheumatology secrets, 3rd edn. Elsevier, pp 179–188
Wilson CL, Burge SM, Dean D, Dawber RPR (1992) Scarring alopecia in discoid lupus erythematosus. Br J Dermatol 126(4):307–314
Woods MT, Gavino AC, Burford HN, Hughey SL, Mercado P, Danila M, Andea AA (2011) The evolution of histopathologic findings in adult still disease. Am J Dermatopathol 33(7):736–739
Yamamoto T (2013) Cutaneous necrobiotic conditions associated with rheumatoid arthritis: important extra-articular involvement. Mod Rheumatol 23(4):617–622
Zancanaro PC, Isaac AR, Garcia LT, Costa IM (2009) Localized scleroderma in children: clinical, diagnostic and therapeutic aspects. An Bras Dermatol 84(2):161–172
Zeitoni NC, Funaro D, Cloutier RA, Gagné E, Claveau J (2000) Redefining Rowell syndrome. Br J Dermatol 142(2):343–346
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this entry
Cite this entry
Reich, A. et al. (2020). The “Connective Tissue Diseases”. In: Smoller, B., Bagherani, N. (eds) Atlas of Dermatology, Dermatopathology and Venereology . Springer, Cham. https://doi.org/10.1007/978-3-319-45134-3_43-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-45134-3_43-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-45134-3
Online ISBN: 978-3-319-45134-3
eBook Packages: Springer Reference MedicineReference Module Medicine